Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Lilly and Emisphere sign agreement

Feb. 28, 1997

Flamel Technologies and SKB conclude collaboration

Feb. 26, 1997

CytoTherapeutics and Cognetix collaborate on CNS R&D

Feb. 24, 1997

DNA sequencing technology available for licensing

Feb. 24, 1997

Transcriptional cofactor offered by NIH

Feb. 24, 1997

ARIAD and Genovo form gene therapy joint venture

Feb. 21, 1997

Inex and Schering-Plough complete research collaboration

Feb. 14, 1997

Alza/Alkermes stock purchase and development agreements

Feb. 14, 1997

Annual Report: CellPro

Feb. 14, 1997

Lilly/Taisho sign technology transfer agreement

Feb. 13, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...